Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01513720 · ClinicalTrials.gov registry record · Phase 1
Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition
A Phase 1 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01513720: Completed Phase 1 study, sponsored by Dr. Reddy's Laboratories Limited.
NCT01513720 is a Phase 1 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01513720, a Phase 1 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is an single dose,two-way, crossover, oral bioequivalence study.
Interventions
- DRUG Lamotrigine
- DRUG Lamictal®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2002-12 |
| Est. Completion | 2002-12 |
| Phase | Phase 1 |
What the finished NCT01513720 record still lists
NCT01513720 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which Lamotrigine is the first listed.
NCT01513720 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01513720 about?
NCT01513720 is a clinical study titled "Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition". This is an single dose,two-way, crossover, oral bioequivalence study.
What is the current status of trial NCT01513720?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2002-12. Estimated completion is 2002-12.
What interventions are being tested in trial NCT01513720?
The interventions under investigation include: Lamotrigine (DRUG), Lamictal® (DRUG).
Who is sponsoring clinical trial NCT01513720?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01513720's enrollment target sits among peer trials
20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia